Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis

The genetic alterations contributing to melanoma pathogenesis are incompletely defined, and few independent prognostic features have been identified beyond the clinicopathological characteristics of the primary tumor. We used transcriptome profiling of 46 primary melanomas, 12 melanoma metastases, a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Invest Dermatol
Asıl Yazarlar: Raskin, Leon, Fullen, Douglas R., Giordano, Thomas J., Thomas, Dafydd G., Frohm, Marcus L., Cha, Kelly B., Ahn, Jaeil, Mukherjee, Bhramar, Johnson, Timothy M., Gruber, Stephen B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4267221/
https://ncbi.nlm.nih.gov/pubmed/23633021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2013.197
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller